- Home
- VCYT vs ALHC Comparison
VCYT vs ALHC Comparison
Compare VCYT & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCYT | ALHC |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.3B |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VCYT | ALHC |
|---|---|---|
| Price | $58.37 | $20.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $44.00 | $23.13 |
| AVG Volume (30 Days) | 1.3M | ★ 5.0M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | 100.00 |
| EPS | ★ 0.35 | 0.05 |
| Revenue | N/A | ★ $3,948,719,000.00 |
| Revenue This Year | $13.76 | $33.69 |
| Revenue Next Year | $12.35 | $24.74 |
| P/E Ratio | ★ $167.77 | $405.50 |
| Revenue Growth | N/A | ★ 46.06 |
| 52 Week Low | $22.92 | $11.63 |
| 52 Week High | $60.91 | $25.12 |
Technical Indicators
Market Signals| Indicator | VCYT | ALHC |
|---|---|---|
| Relative Strength Index (RSI) | 59.85 | 49.75 |
| Support Level | $54.25 | $19.27 |
| Resistance Level | $60.91 | $23.01 |
| Average True Range (ATR) | 2.72 | 1.37 |
| MACD | -0.42 | -0.43 |
| Stochastic Oscillator | 64.19 | 23.40 |
Price Performance
Historical ComparisonAbout VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.